Abstract T MP92: Patient Valuation of Each Level of the Modified Rankin Global Disability Scale: Insights from the Stroke Impact Scale

@article{Chaisinanunkul2014AbstractTM,
  title={Abstract T MP92: Patient Valuation of Each Level of the Modified Rankin Global Disability Scale: Insights from the Stroke Impact Scale},
  author={Napasri N. Chaisinanunkul and Sidney Starkman and Scott A. Hamilton and Fiona Chatfield and Robin A Conwit and Jeffrey L. Saver},
  journal={Stroke},
  year={2014}
}
Background: The modified Rankin Scale (mRS) assessment of global disability is the most commonly used primary endpoint in acute stroke clinical trials and is endorsed for use by US and European drug/device regulatory authorities. However, the mRS is an ordinal scale with ranks an unknown distance apart, hampering identification of minimally clinically important differences in scale outcome distributions. The Stroke Therapy Academic Industry Roundtable and other authorities have called for…